The National Institutes of Health (NIH), through the National Institute of Allergy and Infectious Diseases (NIAID), is inviting applications for the Investigator Initiated Program Project Grants aimed at advancing research in areas pertinent to the NIAID mission. This program encourages small businesses to propose innovative projects that explore the biology and pathogenesis of microbes, immune system functions, and the development of vaccines and therapeutics for infectious and immune-mediated diseases. The grant does not require cost-sharing or matching, with an estimated award date set for December 1, 2026, and applications are due by January 25, 2026. For further inquiries, interested applicants can contact Dr. Chelsea Boyd at chelsea.boyd@nih.gov or by phone at 301-761-6664.

The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for investigator-initiated Program Project applications. The program encourages applications for investigator-initiated program projects proposed in scientific areas relevant to the NIAID mission including the biology, pathogenesis, and host response to microbes; mechanisms regulating immune system development and function across the lifespan, and/or in response to infectious pathogens; immune dysfunction resulting in autoimmunity, immunodeficiency, allergy, asthma, or transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics to prevent and treat infectious, immune-mediated, and allergic diseases. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200. 

Buyer

Eligible Applicants

Funding Category

Funding Instrument

Opportunity Category

Cost Sharing or Matching Requirement

Original Source